{"result": "(\"entity\"<|>AMERICAN COLLEGE OF CARDIOLOGY<|>ORGANIZATION<|>The American College of Cardiology is a professional organization that provides guidelines and recommendations for cardiovascular disease management.)\n##\n(\"entity\"<|>AHA/ACC TASK FORCE ON PRACTICE GUIDELINES<|>ORGANIZATION<|>The AHA/ACC Task Force on Practice Guidelines develops clinical practice guidelines for cardiovascular disease prevention and management.)\n##\n(\"entity\"<|>EUROPEAN SOCIETY OF CARDIOLOGY<|>ORGANIZATION<|>The European Society of Cardiology is a professional organization that focuses on the study and treatment of cardiovascular diseases in Europe.)\n##\n(\"entity\"<|>EUROPEAN ASSOCIATION FOR CARDIOVASCULAR PREVENTION & REHABILITATION<|>ORGANIZATION<|>The EACPR is an organization that contributes to the development of guidelines for cardiovascular disease prevention and rehabilitation.)\n##\n(\"entity\"<|>MEDITERRANEAN DIET<|>EVENT<|>The Mediterranean diet is a dietary pattern that emphasizes the consumption of fruits, vegetables, whole grains, and healthy fats, associated with reduced cardiovascular risk.)\n##\n(\"entity\"<|>PREDIMED TRIAL<|>EVENT<|>The PREDIMED trial is a study that investigates the effects of the Mediterranean diet on cardiovascular disease prevention.)\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASE<|>EVENT<|>Cardiovascular disease refers to a range of conditions affecting the heart and blood vessels, often linked to dietary and lifestyle factors.)\n##\n(\"relationship\"<|>AHA/ACC TASK FORCE ON PRACTICE GUIDELINES<|>AMERICAN COLLEGE OF CARDIOLOGY<|>The AHA/ACC Task Force on Practice Guidelines develops guidelines that are endorsed by the American College of Cardiology<|>8)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY OF CARDIOLOGY<|>AHA/ACC TASK FORCE ON PRACTICE GUIDELINES<|>The European Society of Cardiology collaborates with the AHA/ACC Task Force on Practice Guidelines to create comprehensive cardiovascular guidelines<|>7)\n##\n(\"relationship\"<|>EUROPEAN ASSOCIATION FOR CARDIOVASCULAR PREVENTION & REHABILITATION<|>EUROPEAN SOCIETY OF CARDIOLOGY<|>The EACPR works under the umbrella of the European Society of Cardiology to focus on prevention and rehabilitation in cardiovascular health<|>6)\n##\n(\"relationship\"<|>MEDITERRANEAN DIET<|>PREDIMED TRIAL<|>The PREDIMED trial studies the effects of the Mediterranean diet on cardiovascular disease prevention<|>9)\n##\n(\"relationship\"<|>CARDIOVASCULAR DISEASE<|>MEDITERRANEAN DIET<|>The Mediterranean diet is associated with a reduced risk of cardiovascular disease<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: J Clin Nutr 2001;\n      Task Force on Practice Guidelines. 2013 AHA/ACC                      73: 1019-26.\n      guideline on lifestyle management to reduce car-                31.  Mattson FH, Grundy SM. Comparison of effects of\n      diovascular risk: a report of the American College                   dietary saturated, monounsaturated and polyun-\n      of   Cardiology/American          Heart    Association   Task        saturated fatty acids on plasma lipids and lipopro-\n      Force on Practice Guidelines. J Am Coll Cardiol.                     teins in man. J Lipid Res 1985; 26: 194-202.\n      2014 Jul 1;63(25 Pt B):2960-84.                                 32.  Schwingshackl L, Hoffmann G. Monounsaturated\n20.   Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons                     fatty acids and risk of cardiovascular disease: sy-\n      C, Catapano AL, et al. 2016 European Guidelines                      nopsis of the evidence available from systematic\n      on cardiovascular disease prevention in clinical                     reviews     and    meta-analyses.        Nutrients.     2012;\n      practice: The Sixth Joint Task Force of the Euro-                    4:1989-2007.\n      pean Society of Cardiology and Other Societies on               33.  Kastorini CM, Milionis HJ, Esposito K,             et al.   The\n      Cardiovascular Disease Prevention in Clinical Prac-                  effect of Mediterranean diet on metabolic syndro-\n      tice (constituted by representatives of 10 societies                 me and its components: a meta-analysis of 50 stu-\n      and by invited experts) Developed with the special                   dies and 534,906 individuals. J Am Coll Cardiol.\n      contribution of the European Association for Car-                    2011; 57:1299-313\n      diovascular Prevention & Rehabilitation (EACPR).                34.  Nordmann AJ, Suter-Zimmermann K, Bucher HC,\n      Eur Heart J. 2016; 37: 2315-81.                                      et al. Meta-analysis comparing Mediterranean to\n21.   Katan MB, Zock PL, Mensink RP. Trans fatty acids                     low-fat diets for modification of cardiovascular\n      and their effects on lipoproteins in humans. Annu                    risk factors. Am J Med. 2011; 124:841-51.\n      Rev Nutr 1995; 15: 473-93.                                      35.  Sofi F, Abbate R, Gensini GF, et al. Accruing evi-\n22.   Mensink RP, Katan MB. Effect of dietary trans fatty                  dence on benefits of adherence to the Mediterra-\n      acids on high-density and low-density lipoprotein                    nean diet on health: an updated systematic review\n      cholesterol levels in healthy subjects. N Engl J Med                 and meta-analysis. Am J Clin Nutr. 2010; 92:1189-\n      1990; 323: 439-45.                                                   96.\n23.   Zock PL, Katan MB. Hydrogenation alternatives:                  36.  Martinez-Gonzalez MA, Bes-Rastrollo M. Dietary\n      effects of trans fatty acids and stearic acid versus                 patterns, Mediterranean diet, and cardiovascular\n      linoleic acid on serum lipids and lipoproteins in                    disease. Curr Opin Lipidol. 2014; 25:20-6.\n      humans. J Lipid Res 1992; 33: 399-410.                          37.  Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella\n24.   Mensink RP. Metabolic and health effects of isome-                   D, Arós F, et al. Primary prevention of cardiovascu-\n      ric fatty acids. Curr Opin Lipidol 2005; 16: 27-30.                  lar disease with a Mediterranean diet. N Engl J\n25.   Kromhout D, Menotti A, Bloemberg B, Aravanis C,                      Med. 2013; 368: 1279-90.\n      Blackburn H, Buzina R et al. Dietary saturated and              38.  Martínez-González MÁ, Toledo E, Arós F, et al. Ex-\n      trans fatty acids and cholesterol and 25-year mor-                   travirgin olive oil consumption reduces risk of atrial\n      tality   from    coronary     heart    disease:    the  Seven        fibrillation: the PREDIMED (Prevención con Dieta\n      Countries Study. Prev Med 1995; 24: 308-15.                          Mediterránea) trial. Circulation. 2014; 130: 18-26.\n26.   Aro A, Kardinaal AF, Salminen I, Kark JD, Riemers-              39.  Salas-Salvadó J, Bulló M, Estruch R, et al. Preven-\n      ma RA, Delgado-Rodríguez M, et al. Adipose tis-                      tion of diabetes with Mediterranean diets: a sub-\n---\n                          Tema 19.      Influencia de la dieta en el control de la hiperlipemia y el riesgo cardiovascular                    341\n\n\n\n     group analysis of a randomized trial. Ann Intern                              polyuns\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}